Patents Assigned to Cobra Therapeutics, Ltd.
  • Glycine-containing sequences conferring invisibility to the immune system
    Patent number: 5833991
    Abstract: The invention provides compositions and methods for preventing undesired immune responses in which a recombinant protein is prepared which includes a glycine-containing amino acid sequence, protein substantial invisibility to the immune system.
    Type: Grant
    Filed: September 15, 1995
    Date of Patent: November 10, 1998
    Assignee: Cobra Therapeutics, Ltd.
    Inventor: Maria G. Masucci
  • Compositions for insulin-receptor mediated nucleic acid delivery
    Patent number: 5830852
    Abstract: The invention is based on the discovery of a pharmaceutical preparation for use in gene therapy which includes a therapeutic nucleic acid associated with Insulin-NHCO--CH.sub.2 --O--N.dbd.CH--C-Lys.sub.18 -Cys(S-Pyridyl)-OH in combination with a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: December 18, 1996
    Date of Patent: November 3, 1998
    Assignee: Cobra Therapeutics, Ltd.
    Inventors: David R. Thatcher, Robin E. Offord, Keith Rose, Hubert F. Gaertner